Rani E George MD

Pediatric Hematology & Oncology•Boston, MA

Pediatric Solid Tumor Oncology

Assistant Professor, Pediatrics, Children's Hospital, Harvard Medical School

450 Brookline Ave# DanaBoston, MA 02215
Phone+1 617-632-5281

Dr. George is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. George's full profile Already have an account?

Education & Training

Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2002 - 2004
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1999 - 2002
A. M. Dogliotti School of MedicineClass of 1985

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2002 - 2027
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma
COMPLETED
PHASE1

Publications & Presentations

PubMed

Developmental reprogramming underlies chemotherapy resistance in favorable-histology Wilms tumor.
Andrew M Fleming, Carolyn M Jablonowski, Hongjian Jin, Siwei Zhang, Surbhi Sona
Cell Reports. 2026-03-24
Histologic Response to Induction Chemotherapy in High-Risk Neuroblastoma.
Monica Pomaville, Pei-Chi Kao, Antonio Perez-Atayde, Wendy B London, Rani E George
Cancer Medicine. 2025-11-01
7 citations
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum.
Steven G DuBois, Lucas Moreno, John Anderson, Shahab Asgharzadeh, Ro Bagatell
Pediatric Blood & Cancer. 2025-09-01

Press Mentions

Meet BORIS: Possible New Culprit in Drug-Resistant CancerSeptember 25th, 2019
Researchers Take New Approach to Stop 'Most Wanted' Cancer ProteinNovember 7th, 2014